New dengue vaccine TAK-003 gains WHO prequalification for high-burden areas

FHS
May 20, 2024
8:07 am

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue.

Florida Supreme Court upholds state’s 15-week ban on most abortions, paving way for 6-week ban

TALLAHASSEE, Fla. — The Florida Supreme Court on Monday upheld the state’s ban on most abortions after 15 weeks of pregnancy, which means a subsequently

April 1, 2024

Soldiers’ Mysterious Injuries; Doctor’s Resignation Worries Families; Recall Harms

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Military Unit’s Mysterious Injuries The Marines

November 9, 2023

Medtronic expected to prevail at FDA renal denervation vote despite data doubts: analysts

Dive Brief: Analysts at Needham expect a U.S. Food and Drug Administration advisory panel to support the safety and efficacy of Medtronic’s renal denervation device

August 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.